Bioactive Natural Products : Chemistry and Biology /
Natural compounds, which have evolved their function over millions of years, are often more efficient than man-made compounds if a specific biological activity is needed, e.g. as an enzyme inhibitor or as a toxin to kill a cancer cell. This book comprising of sixteen technical chapters, highlights t...
| Άλλοι συγγραφείς: | |
|---|---|
| Μορφή: | Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Weinheim, Germany :
Wiley-VCH,
2015.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Bioactive Natural Products; Contents; Foreword; Preface; About the Editor; List of Contributors; Chapter 1 An Overview; 1.1 Introduction; 1.2 An Overview of the Book; 1.2.1 Chapter 2; 1.2.2 Chapter 3; 1.2.3 Chapter 4; 1.2.4 Chapter 5; 1.2.5 Chapter 6; 1.2.6 Chapter 7; 1.2.7 Chapter 8; 1.2.8 Chapter 9; 1.2.9 Chapter 10; 1.2.10 Chapter 11; 1.2.11 Chapter 12; 1.2.12 Chapter 13; 1.2.13 Chapter 14; 1.2.14 Chapter 15; 1.2.15 Chapter 16; 1.2.16 Chapter 17; 1.3 Concluding Remarks; Chapter 2 Use of Chemical Genomics to Investigate the Mechanism of Action for Inhibitory Bioactive Natural Compounds.
- 2.1 Introduction: Antibiotic Resistance and the Use of Natural Products as a Source for Novel Antimicrobials2.2 Chemical Genetics and Genomics; 2.3 Development of GDA Technology; 2.3.1 The Use of Gene Deletion Arrays (GDAs) to Investigate MOA; 2.3.2 Chemical Genetic Interactions; 2.3.3 Quantifying Genetic and Chemical Genetic Interactions; 2.3.4 Data Analysis; 2.3.5 Platforms for Chemical Genomic GDA Studies; 2.3.6 Why Screen Natural Products in GDAs?; 2.3.7 Successful Applications of GDA Technology; 2.4 Concluding Remarks; Abbreviations; References.
- Chapter 4 Immunosuppressants: Remarkable Microbial Products4.1 Introduction; 4.2 Discovery; 4.3 Mode of Action; 4.4 Biosynthesis; 4.4.1 Acetate, Propionate, Butyrate, Methionine, and Valine as Precursors of the Macrolide Rings of Sirolimus, Ascomycin, and Tacrolimus; 4.4.2 Pipecolate Moiety of the Macrolide Ring of Sirolimus, Ascomycin, and Tacrolimus; 4.4.3 The Final Step in Biosynthesis of Ascomycins and Tacrolimus; 4.4.4 Formation of the Substituted Cyclohexyl Moiety of Sirolimus, Tacrolimus, and Ascomycins; 4.4.5 Biosynthesis of Cyclosporin; 4.5 Genetics and Strain Improvement.
- 4.6 Fermentation and Nutritional Studies4.7 Other Activities of Immunosuppressants; 4.8 Concluding Remarks; Acknowledgments; References; Chapter 5 Activators and Inhibitors of ADAM-10 for Management of Cancer and Alzheimer's Disease; 5.1 Introduction to ADAM Family of Enzymes; 5.2 ADAM-10 Structure and Physiological Roles; 5.3 Pathological Significance; 5.3.1 Modulating ADAM Activity in Neurodegeneration; 5.3.2 ADAM-10 in Cancer Pathology; 5.4 ADAM-10 as Potential Drug Target; 5.5 Synthetic Inhibitors of ADAM-10; 5.6 Natural Products as Activators and Inhibitors for ADAM-10.
